Michael Rapp's Net Worth

$37.6 Million

Estimate Recalculated Jul 2, 2024 04:44PM EST

Who is Michael Rapp?

Michael Rapp has an estimated net worth of $37.6 Million. This is based on reported shares across multiple companies, which include COMMITTED CAPITAL ACQUISITION Corp, Immunome Inc., Zynerba Pharmaceuticals, Inc., PLASTRON ACQUISITION CORP I, PLASTRON ACQUISITION CORP III, and PLASTRON ACQUISITION CORP IV.

SEC CIK

Michael Rapp's CIK is 0001405685

Past Insider Trading and Trends

2021 was Michael Rapp's most active year for acquiring shares with 8 total transactions. Michael Rapp's most active month to acquire stocks was the month of September. 2011 was Michael Rapp's most active year for disposing of shares, totalling 2 transactions. Michael Rapp's most active month to dispose stocks was the month of March. 2023 saw Michael Rapp paying a total of $1,569,993.46 for 277,806 shares, this is the most they've acquired in one year. In 2011 Michael Rapp cashed out on 2,303,802 shares for a total of $7,441.88, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COMMITTED CAPITAL ACQUISITION Corp (STKS) Snapshot price: $3.94

President and Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.65%
163.06K
$5.00
$815,280.00
1.56M
Oct 16
Form 4
-5.72%
-197.25K
—
—
3.25M
Apr 23
Form 4
-2.36%
-82.75K
—
—
3.43M
Jun 19
Form 4
-2.38%
-89.79K
—
—
3.68M
Mar 1
Form 4
-37.25%
-2.28M
—
—
3.85M
May 27
Form 3
—
0
—
—
0
No matching records found

Immunome Inc. (IMNM) Snapshot price: $25.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+31.05%
253.81K
$5.91
$1,499,993.46
1.07M
Oct 2
Form 4
—
0
—
—
0
Jun 8
Form 4
+2.19%
17.5K
$4.00
$70,000.00
817.37K
Jan 15
Form 4
—
0
—
—
0
Jun 16
Form 4
+14.20%
25.96K
$19.96
$518,201.52
208.74K
Sep 13
Form 4
+33.58%
45.95K
$18.07
$830,448.60
182.78K
Sep 9 - Sep 10
Form 4
—
0
—
—
0
May 28
Form 4
+64.20%
53.5K
$18.38
$983,423.06
136.83K
May 24 - May 26
Form 4
—
0
—
—
0
Nov 3
Form 4
∞
638.89K
$12.00
—
638.89K
Oct 6
Form 3
—
0
—
—
0
No matching records found

Zynerba Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.39%
5.88K
$10.45
$61,498.25
1.5M
May 30
Form 4
+1.01%
15K
$10.46
$156,945.00
1.49M
May 2
Form 4
+0.68%
10K
$9.28
$92,790.00
1.48M
Mar 22
Form 4
+1.03%
15K
$12.99
$194,847.00
1.47M
Jan 2
Form 4
+7.38%
100K
$9.74
$973,738.05
1.45M
Oct 19 - Oct 23
Form 4
+0.74%
10K
$15.85
$158,500.00
1.35M
Dec 29
Form 4
+6.37%
80.47K
—
—
1.34M
Feb 2
Form 4
+81.52%
567.5K
—
—
1.26M
Aug 10
Form 3
—
0
—
—
0
No matching records found

PLASTRON ACQUISITION CORP I No price found

President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

PLASTRON ACQUISITION CORP III No price found

President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found